U S PHYSICAL THERAPY INC /NV (USPH)

Import this data to Google Sheets with:

=jivedata("USPH","financials")

Full statements spill as a table. For one cell: =jivedata("USPH","Revenue") or =jivedata("USPH","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

U S PHYSICAL THERAPY INC /NV

USPH • CIK 0000885978

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss) Attributable to Parent	$28,239	$31,424	$39,583	$32,227
Weighted Average Number of Shares Outstanding, Basic	14,188,000	15,064,000	15,175,000	15,128,000

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$152,825	$41,362	$35,570	$24,887
Accounts Receivable, after Allowance for Credit Loss, Current	$51,866	$59,040	$64,249	$69,603
Accounts and Other Receivables, Net, Current	$17,854	$26,626	$24,087	$28,557
Operating Lease, Right-of-Use Asset	$103,431	$133,936	$144,197	$156,466
Other Assets, Current	$10,830	$10,555	$16,084	$16,628
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures	$12,256	$12,190	$12,275	$12,712
Assets, Current	$233,375	$137,583	$139,990	$139,675
Goodwill	$509,571	$667,152	$692,392	$716,535
Intangible Assets, Net (Excluding Goodwill)	$109,682	$179,311	$172,861	$176,547
Other Assets, Noncurrent	$2,821	$5,155	$6,644	$6,505
Assets	$997,238	$1,167,467	$1,204,010	$1,248,874
Furniture and Fixtures, Gross	$63,982	$68,128	$67,891	$74,132
Leasehold Improvements, Gross	$46,941	$51,105	$58,985	$60,397
Notes Payable, Noncurrent	$1,289	$903	$417	$890
Property, Plant and Equipment, Gross	$110,923	$119,233	$126,876	$134,529
Long-term Line of Credit, Noncurrent	$0	$11,000	$30,500	$46,000
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	$84,821	$87,093	$91,225	$94,095
Loans Payable, Noncurrent	$137,702	$130,627	$121,677	$168,566
Property, Plant and Equipment, Net	$26,102	$32,140	$35,651	$40,434
Deferred Income Tax Liabilities, Net	$24,815	$29,465	$28,391	$30,998
Operating Lease, Liability, Noncurrent	$76,653	$101,868	$110,572	$122,899
Other Liabilities, Noncurrent	$2,356	$18,275	$3,214	$2,954
Liabilities	$345,000	$408,421	$433,811	$482,216
Redeemable Noncontrolling Interest, Equity, Carrying Amount	$174,828	$269,025	$293,311	$317,491
Stockholders' Equity Attributable to Noncontrolling Interest	$1,216	$1,092	$456	$511
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	$477,410	$490,021	$476,888	$449,167
Accounts Payable, Trade, Current	$3,898	$5,936	$6,059	$6,917
Accrued Liabilities, Current	$55,344	$59,513	$80,982	$45,424
Operating Lease, Liability, Current	$35,252	$39,835	$42,134	$42,871
Long-term Debt, Current Maturities	$7,691	$10,999	$9,865	$4,563
Liabilities, Current	$102,185	$116,283	$139,040	$109,909
Preferred Stock, Value, Issued	$0	$0	$0	$0
Common Stock, Value, Issued	$172	$172	$174	$175
Additional Paid in Capital	$281,096	$290,321	$285,522	$290,551
Accumulated Other Comprehensive Income (Loss), Net of Tax	$2,782	$2,799	$714	$1,047
Retained Earnings (Accumulated Deficit)	$223,772	$227,265	$227,216	$213,361
Treasury Stock, Value	$31,628	$31,628	$37,194	$56,478
Stockholders' Equity Attributable to Parent	$476,194	$488,929	$476,432	$448,656
Accounts Receivable, Allowance for Credit Loss, Current	$2,736	$3,506	$3,775	$3,824
Preferred Stock, Shares Authorized	500,000	500,000	500,000	500,000
Preferred Stock, Shares Issued	0	0	0	0
Common Stock, Shares Authorized	20,000,000	20,000,000	20,000,000	20,000,000
Common Stock, Shares, Issued	17,202,291	17,309,120	17,418,621	17,526,791
Treasury Stock, Common, Shares	2,214,737	2,214,737	2,296,059	2,603,117
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits	$1,680	$2,370	$2,045	$2,045
Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Allowance for Doubtful Accounts	$574	$747	$792	$792
Deferred Tax Assets, Other	—	—	$94	$94
Deferred Tax Assets, Gross	$30,846	$39,322	$32,819	$32,819
Deferred Tax Liabilities, Property, Plant and Equipment	$27,290	$32,392	$31,274	$31,274
Deferred Tax Liabilities, Other	$403	$576	$1,271	$1,271
Deferred Tax Liabilities, Gross	$55,661	$68,787	$61,210	$61,210

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$37,220	$45,600	$58,005	$49,871
Net Cash Provided by (Used in) Operating Activities	$81,978	$74,940	$75,058	$83,050
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$121,231	$-111,463	$-5,792	$-9,199
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$152,825	$41,362	$35,570	$24,826
Depreciation, Depletion and Amortization	$15,695	$18,681	$22,391	$22,402
Payments to Acquire Productive Assets	$9,294	$9,186	$14,071	$18,978
Accounts Receivable, Credit Loss Expense (Reversal)	$6,172	$6,912	$7,647	$7,928
Payments to Acquire Businesses, Net of Cash Acquired	$26,582	$133,087	$15,674	$29,917
Share-based Payment Arrangement, Noncash Expense	$7,236	$7,823	$8,270	$9,861
Amortization of Debt Issuance Costs	$420	$422	$422	$424
Payments to Acquire Interest in Subsidiaries and Affiliates	$281	$1,004	$273	$9,097
Deferred Federal, State and Local, Tax Expense (Benefit)	$4,490	$5,365	$11,406	$11,406
Proceeds from Divestiture of Interest in Subsidiaries and Affiliates	$875	$79	$186	$392
Income (Loss) from Equity Method Investments	$955	$1,014	$1,477	$1,455
Gain (Loss) on Disposition of Property Plant Equipment	$-166	$-836	$-383	$-247
Payments for (Proceeds from) Limited Partnership	$0	$0	$-700	$0
Payments for (Proceeds from) Other Investing Activities	$-321	$-694	$-364	$-301
Goodwill and Intangible Asset Impairment	$17,495	$0	$0	$0
Net Cash Provided by (Used in) Investing Activities	$-45,015	$-149,450	$-36,713	$-63,586
Impairment of Long-Lived Assets to be Disposed of	—	$2,418	$0	$0
Increase (Decrease) in Accounts Receivable	$5,645	$5,346	$11,955	$10,770
Proceeds from Issuance of Common Stock	$163,646	$0	$0	$0
Increase (Decrease) in Accounts Receivable and Other Operating Assets	$356	$6,548	$-2,895	$422
Proceeds from Lines of Credit	$24,000	$19,000	$189,500	$269,262
Increase (Decrease) in Other Operating Assets	$197	$818	$10,418	$5,918
Payments of Ordinary Dividends, Noncontrolling Interest	$16,100	$14,711	$19,269	$20,898
Increase (Decrease) in Accounts Payable and Accrued Liabilities	$15	$1,713	$-7,798	$-1,294
Payments of Ordinary Dividends, Common Stock	$24,128	$26,540	$27,362	$27,555
Increase (Decrease) in Other Noncurrent Liabilities	$1,254	$-1,405	$86	$-48
Repayments of Lines of Credit	$55,000	$8,000	$170,000	$247,762
Repayments of Long-term Debt	$3,750	$3,750	$9,375	$5,625
Payments for Repurchase of Common Stock	—	—	$5,566	$24,799
Repayments of Notes Payable	$4,400	$2,952	$2,065	$1,054
Net Cash Provided by (Used in) Financing Activities	$84,268	$-36,953	$-44,137	$-28,663
Noncash or Part Noncash Acquisition, Value of Liabilities Assumed	$524	$670	$0	$0
Proceeds from Noncontrolling Interests	$4,136	$1,890	$0	$0
Income Taxes Paid, Net	$4,926	$4,832	$14,348	$9,284
Interest Paid, Excluding Capitalized Interest, Operating Activities	$8,655	$7,209	$9,431	$11,337

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("USPH","financials")

Full statements spill as a table. For one cell: =jivedata("USPH","Revenue") or =jivedata("USPH","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.